Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Significant Decrease in Short Interest

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the target of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 70,200 shares, a decline of 31.2% from the January 31st total of 102,100 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.

Shin Nippon Biomedical Laboratories Stock Performance

SBLOF opened at $9.82 on Wednesday. Shin Nippon Biomedical Laboratories has a twelve month low of $9.82 and a twelve month high of $9.82. The company’s 50-day moving average price is $9.82 and its two-hundred day moving average price is $13.45.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies.